200 related articles for article (PubMed ID: 31870403)
81. Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities.
Lin MH; Price RA; Li J; Kang S; Li J; Ma CM
Phys Med Biol; 2013 Nov; 58(22):8179-96. PubMed ID: 24200917
[TBL] [Abstract][Full Text] [Related]
82. Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy.
Moon YM; Bae SI; Han MJ; Jeon W; Yu T; Choi CW; Kim JY
Technol Cancer Res Treat; 2021; 20():15330338211059937. PubMed ID: 34821195
[TBL] [Abstract][Full Text] [Related]
83. The comparison of VMAT test results for Clinac 2300C/D and TrueBeam accelerators.
Latala A; Fujak E; Walewska A; Kukołowicz P
Med Dosim; 2020 Autumn; 45(3):219-224. PubMed ID: 32008886
[TBL] [Abstract][Full Text] [Related]
84. Dosimetric impact and detectability of multi-leaf collimator positioning errors on Varian Halcyon.
Gay SS; Netherton TJ; Cardenas CE; Ger RB; Balter PA; Dong L; Mihailidis D; Court LE
J Appl Clin Med Phys; 2019 Aug; 20(8):47-55. PubMed ID: 31294923
[TBL] [Abstract][Full Text] [Related]
85. Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy.
Hirashima H; Nakamura M; Miyabe Y; Uto M; Nakamura K; Mizowaki T
Radiat Oncol; 2018 Feb; 13(1):27. PubMed ID: 29444693
[TBL] [Abstract][Full Text] [Related]
86. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
[TBL] [Abstract][Full Text] [Related]
87. A hybrid planning strategy for stereotactic body radiation therapy of early stage non-small-cell lung cancer.
Liu H; Sintay B; Pearman K; Shang Q; Hayes L; Maurer J; Vanderstraeten C; Wiant D
J Appl Clin Med Phys; 2018 Nov; 19(6):117-123. PubMed ID: 30281198
[TBL] [Abstract][Full Text] [Related]
88. Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report.
Fusella M; Cavinato S; Germani A; Paiusco M; Pivato N; Rossato MA; Scott A; Scaggion A
Radiat Oncol; 2021 Nov; 16(1):226. PubMed ID: 34809645
[TBL] [Abstract][Full Text] [Related]
89. Quantified VMAT plan complexity in relation to measurement-based quality assurance results.
Nguyen M; Chan GH
J Appl Clin Med Phys; 2020 Nov; 21(11):132-140. PubMed ID: 33112467
[TBL] [Abstract][Full Text] [Related]
90. The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT.
Kim JI; Park SY; Kim HJ; Kim JH; Ye SJ; Park JM
Radiat Oncol; 2014 Jul; 9():167. PubMed ID: 25070065
[TBL] [Abstract][Full Text] [Related]
91. Do technological advances in linear accelerators improve dosimetric outcomes in stereotaxy? A head-on comparison of seven linear accelerators using volumetric modulated arc therapy-based stereotactic planning.
Sarkar B; Pradhan A; Munshi A
Indian J Cancer; 2016; 53(1):166-73. PubMed ID: 27146771
[TBL] [Abstract][Full Text] [Related]
92. Virtual pretreatment patient-specific quality assurance of volumetric modulated arc therapy using deep learning.
Yoganathan SA; Ahmed S; Paloor S; Torfeh T; Aouadi S; Al-Hammadi N; Hammoud R
Med Phys; 2023 Dec; 50(12):7891-7903. PubMed ID: 37379068
[TBL] [Abstract][Full Text] [Related]
93. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
[TBL] [Abstract][Full Text] [Related]
94. Assessing the sensitivity and suitability of a range of detectors for SIMT PSQA.
Dunn L; Tamborriello A; Subramanian B; Xu X; Ruruku TT
J Appl Clin Med Phys; 2024 May; 25(5):e14343. PubMed ID: 38569013
[TBL] [Abstract][Full Text] [Related]
95. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT.
Lee TF; Ting HM; Chao PJ; Fang FM
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):196-207. PubMed ID: 21752615
[TBL] [Abstract][Full Text] [Related]
96. A synthesized gamma distribution-based patient-specific VMAT QA using a generative adversarial network.
Matsuura T; Kawahara D; Saito A; Yamada K; Ozawa S; Nagata Y
Med Phys; 2023 Apr; 50(4):2488-2498. PubMed ID: 36609669
[TBL] [Abstract][Full Text] [Related]
97. Statistical analysis of correlation of gamma passing results for two quality assurance phantoms used for patient-specific quality assurance in volumetric modulated arc radiotherapy.
Kunii Y; Tanabe Y; Nakamoto A; Nishioka K
Med Dosim; 2022 Winter; 47(4):329-333. PubMed ID: 35850758
[TBL] [Abstract][Full Text] [Related]
98. Using machine learning to predict gamma passing rate in volumetric-modulated arc therapy treatment plans.
Salari E; Shuai Xu K; Sperling NN; Parsai EI
J Appl Clin Med Phys; 2023 Feb; 24(2):e13824. PubMed ID: 36495010
[TBL] [Abstract][Full Text] [Related]
99. Sensitivity of a helical diode array dosimeter to Volumetric Modulated Arc Therapy delivery errors.
Arumugam S; Xing A; Young T; Holloway L
Phys Med; 2015 Dec; 31(8):1043-1054. PubMed ID: 26429384
[TBL] [Abstract][Full Text] [Related]
100. Commissioning of volumetric modulated arc therapy (VMAT).
Bedford JL; Warrington AP
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):537-45. PubMed ID: 19147018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
